Monitor the trajectory of Clinic-Level Adjusted EBITDA — it doubled QoQ to $333K, suggesting the clinic platform is approaching self-sufficiency. The next catalyst is whether consolidated Adjusted EBITDA can turn positive as corporate overhead is spread across a larger revenue base. The $2.5M Birmingham remeasurement gain is non-recurring, so focus on operating cash flow and organic revenue growth in subsequent quarters.
Price Chart
Executive Summary
INVO Fertility reported Q2 2026 revenue of $2.18M (+17% YoY) and net income of $0.9M, swinging from a $(3.6)M loss in Q2 2025, driven by a $2.5M gain on remeasurement from the Birmingham acquisition. The clinic platform generated $333K in Clinic-Level Adjusted EBITDA (up from $164K in Q1 2026), but consolidated Adjusted EBITDA remained negative at $(1.0)M. The company ended the quarter with $3.7M cash and 2.5M shares outstanding, with no consensus estimates available for comparison, making the earnings surprise unquantifiable. The filing is neutral as the headline net income swing is non-operational and the core business remains unprofitable on an operating basis, though revenue growth and clinic-level profitability are incremental positives.
Key Financial Metrics
Key Facts
- Q2 2026 revenue of $2,175,485, up 17% YoY from $1,863,654
- Net income of $888,740 vs net loss of $(3,618,969) in Q2 2025, driven by a $2.5M gain on remeasurement from the Birmingham acquisition
- Clinic-Level Adjusted EBITDA improved to $333,026 in Q2 2026 from $163,945 in Q1 2026
- Consolidated Adjusted EBITDA was $(1,032,660) vs $(587,229) in Q2 2025
- Cash balance of $3.7M at June 30, 2026, up from $2.1M at December 31, 2025
- 2,506,969 shares outstanding as of August 14, 2026
- Birmingham clinic converted from joint venture to wholly owned subsidiary in June 2026
Financial Impact
Revenue growth of $311,831 (17% YoY); net income swing of $4.5M driven by $2.5M non-operational gain; cash burn continues with negative operating cash flow
Risk Factors
- Consolidated Adjusted EBITDA remains deeply negative at $(1.0)M, indicating corporate overhead still exceeds clinic-level profits
- Cash burn continues — $3.7M cash on hand may require additional financing if losses persist
- No consensus estimates available, making it impossible to gauge market expectations or surprise magnitude
- Micro-cap with $2M market cap — extreme volatility and low liquidity amplify any news impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-038648 |
| Document: form8-k.htm | 0001493152-26-038648 |
| Document: 0001493152-26-038648-index-headers.html | 0001493152-26-038648 |
| Document: 0001493152-26-038648-index.html | 0001493152-26-038648 |
| Document: 0001493152-26-038648.txt | 0001493152-26-038648 |
| 8-K Data (Synthetic) | 0001493152-26-038648 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | SC 13G/A | $0.7275 $0.5576 | ▲ +23.35% | ▲ +21.39% | $0.5700 (+21.65%) |
Aug 28, 2026 8w ago | 8-K | $1.00 $0.9850 | ▲ +1.50% | ▲ +1.61% | $0.5700 (+43.00%) |
Aug 17, 2026 10w ago | 8-K | $1.53 $1.03 | ▼ −32.68% | ▼ −31.49% | $0.5700 (−62.75%) |
Aug 17, 2026 10w ago | Press Release | $1.53 $1.03 | ▲ +32.68% | ▲ +31.49% | $0.5700 (+62.75%) |
Aug 5, 2026 11w ago | EFFECT | $1.08 $1.01 | ▲ +6.05% | ▲ +6.40% | $0.5700 (+46.98%) |
Jun 25, 2026 17w ago | 8-K | $2.45 $1.62 | ▼ −33.88% | ▼ −36.04% | $0.5700 (−76.73%) |
Jun 22, 2026 18w ago | Press Release | $1.39 $2.45 | ▼ −76.26% | ▼ −78.33% | $0.5700 (+58.99%) |
Jun 16, 2026 18w ago | 8-K | $1.59 $1.32 | ▼ −16.98% | ▼ −15.94% | $0.5700 (−64.15%) |
Jun 2, 2026 20w ago | Press Release | $1.70 $1.41 | ▲ +17.06% | ▲ +13.24% | $0.5700 (+66.47%) |
Jun 2, 2026 21w ago | 8-K | $1.52 $1.40 | ▼ −7.89% | ▼ −4.93% | $0.5700 (−62.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers